Placebo effect in children with acute pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029938

Enrollment

140

Registered

2022-08-02

Start date

2022-08-26

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R52.0 F41.1

Interventions

Group 1: raspberry juice is applicated (placebo) Group 2: raspberry juice is not applicated (control group)

Eligibility

Sex/Gender

All

Age

8 Years to 14 Years

Inclusion criteria

Inclusion criteria: children between 8 an 14 years old with the medical indication for a peripheral venous cannulae who are able to evaluate pain and anxiety themselves

Exclusion criteria

Exclusion criteria: (1) not able to evaluate pain/anxiety themselves, (2) younger than 8 years OR older than 14 years old, (3)chronic pain, (4) language barrier, (5)children who received painkillers and/or anxiolytic medication the same day

Design outcomes

Primary

Measure	Time frame
pain (VAS) and anxiety (STAIK) before and after intervention	—

Secondary

Measure	Time frame
stress before and after intervention (cortisole level in saliva)	—

Countries

Germany

Contacts

Public ContactEva Tschiedel

Universitätsklinikum Essen

eva.tschiedel@uk-essen.de00492017232251

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026